GA2LEN/EAACI pocket guide for allergen‐specific immunotherapy for allergic rhinitis and asthma
- 7 September 2010
- Vol. 65 (12), 1525-1530
- https://doi.org/10.1111/j.1398-9995.2010.02474.x
Abstract
To cite this article: Zuberbier T, Bachert C, Bousquet PJ, Passalacqua G, Walter Canonica G, Merk H, Worm M, Wahn U, Bousquet J. GA2LEN/EAACI pocket guide for allergen‐specific immunotherapy for allergic rhinitis and asthma. Allergy 2010; 65: 1525–1530. Abstract This pocket guide is the result of a consensus reached during several GA2LEN and EAACI meetings. The aim of the current pocket guide is to offer a comprehensive set of recommendations on the use of immunotherapy in allergic rhinoconjunctivitis and asthma in daily practice. This pocket guide is meant to give simple answers to the most frequent questions of practitioners in Europe, including ‘practising allergists’, general practitioners and any other physicians with special interest in allergen‐specific immunotherapy (SIT). It is not a long or detailed scientific review of the topic. However, the recommendations in this pocket guide were compiled following an in‐depth review of existing guidelines and publications, including the 1998 EAACI position paper, the 1998 WHO Position Paper on SIT and the 2001 Allergic Rhinitis and its Impact on Asthma (ARIA). It is also based on the ARIA update 2008 (prepared in collaboration with GA2LEN), the ‘Sub‐lingual Immunotherapy: WAO Position Paper 2009’ (from the World Allergy Organisation) and the Methodology paper of ARIA. The recommendations cover patient selection, allergen extract to be used, route of administration of SIT (in particular, sublingual and subcutaneous immunotherapy), and necessary precautions to be followed in using SIT.Keywords
This publication has 24 references indexed in Scilit:
- Sub‐lingual Immunotherapy: World Allergy Organization Position Paper 2009Allergy, 2009
- The CONSORT statement checklist in allergen‐specific immunotherapy: a GA2LEN paperAllergy, 2009
- Unmet needs in severe chronic upper airway disease (SCUAD)Journal of Allergy and Clinical Immunology, 2009
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*Allergy, 2008
- Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and ElaborationAnnals of Internal Medicine, 2008
- Methodology for development of the Allergic Rhinitis and its Impact on Asthma Guideline 2008 updateAllergy, 2007
- Allergic Rhinitis and Its Impact on AsthmaJournal of Allergy and Clinical Immunology, 2001
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsThe Lancet, 2001
- Local immunotherapyAllergy, 1998
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996